A pilot study of monoclonalantibody cG250 and low dose subcutaneous IL-2 in patients with advanced renalcell carcinoma

[摘要]

[发布日期] [发布机构]

[效力级别] [学科分类] 肿瘤学

[关键词] clinical trial;renalcell carcinoma;human CA9 protein;cG250;chimericantibody;IL-2 [时效性]

浏览次数：12